CHA
AMGN icon

Carmichael Hill & Associates’s Amgen AMGN Stock Holding History

Carmichael Hill & Associates’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$223K Buy
693
+91
+15% +$29.8K 0.08% 174
2024
Q2 		$188K Sell
602
-202
-25% -$59.3K 0.07% 179
2024
Q1 		$229K Sell
804
-64
-7% -$18.7K 0.09% 159
2023
Q4 		$250K Hold
868
– – 0.1% 153
2023
Q3 		$233K Hold
868
– – 0.11% 146
2023
Q2 		$193K Hold
868
– – 0.09% 171
2023
Q1 		$210K Hold
868
– – 0.1% 151
2022
Q4 		$228K Hold
868
– – 0.12% 145
2022
Q3 		$196K Sell
868
-101
-10% -$24.5K 0.11% 151
2022
Q2 		$236K Sell
969
-54
-5% -$13.2K 0.12% 138
2022
Q1 		$247K Hold
1,023
– – 0.11% 148
2021
Q4 		$230K Sell
1,023
-45
-4% -$9.5K 0.1% 165
2021
Q3 		$227K Hold
1,068
– – 0.11% 155
2021
Q2 		$260K Sell
1,068
-2
-0.2% -$492 0.13% 136
2021
Q1 		$266K Hold
1,070
– – 0.15% 128
2020
Q4 		$246K Hold
1,070
– – 0.14% 125
2020
Q3 		$272K Buy
1,070
+67
+7% +$16.6K 0.18% 108
2020
Q2 		$237K Hold
1,003
– – 0.17% 112
2020
Q1 		$203K Hold
1,003
– – 0.18% 111
2019
Q4 		$242K Sell
1,003
-83
-8% -$18.3K 0.17% 112
2019
Q3 		$210K Sell
1,086
-235
-18% -$45.1K 0.21% 102
2019
Q2 		$243K Sell
1,321
-53
-4% -$9.49K 0.24% 98
2019
Q1 		$261K Buy
1,374
+2
+0.1% +$382 0.27% 91
2018
Q4 		$267K Sell
1,372
-74
-5% -$14.4K 0.3% 85
2018
Q3 		$300K Hold
1,446
– – 0.29% 86
2018
Q2 		$267K Buy
1,446
+1
+0.1% +$177 0.29% 87
2018
Q1 		$246K Sell
1,445
-29
-2% -$5.32K 0.27% 97
2017
Q4 		$256K Buy
+1,474
New +$261K 0.28% 92

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Carmichael Hill & Associates's AMGN Position: Q3 2024 in Review

Carmichael Hill & Associates increased its Amgen (AMGN) stake by 15% in Q3 2024, buying an estimated $29.8K and bringing the position to 693 shares worth $223K. The position accounts for 0.08% of the portfolio, ranked #174.

Carmichael Hill & Associates first reported a position in AMGN in Q4 2017 and has held it in 28 quarters since. The position peaked at $300K in Q3 2018. 2,823 funds tracked by Wall St. Rank hold AMGN as of Q3 2024.

  • Carmichael Hill & Associates held 693 shares of Amgen worth $223K as of Q3 2024.
  • Carmichael Hill & Associates bought 91 Amgen shares in Q3 2024, an estimated $29.8K.
  • Amgen made up 0.08% of Carmichael Hill & Associates's portfolio in Q3 2024, its #174 holding.
  • Carmichael Hill & Associates first reported a position in Amgen in Q4 2017 and has held it in 28 quarters since.
  • Carmichael Hill & Associates's Amgen position peaked at $300K in Q3 2018.
  • 2,823 funds tracked by Wall St. Rank held Amgen as of Q3 2024.

Based on Carmichael Hill & Associates's 13F filing for Q3 2024, filed 29 Oct 2024.